Judith G Regensteiner1, Timothy A Bauer, Amy G Huebschmann, Leah Herlache, Howard D Weinberger, Eugene E Wolfel, Jane E B Reusch. 1. 1Department of Medicine, Division of Internal Medicine, University of Colorado School of Medicine, Aurora, CO; 2Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, Aurora, CO; 3Department of Medicine, Center for Women's Health Research, University of Colorado School of Medicine, Aurora, CO; 4Division of Endocrinology, University of Colorado School of Medicine, Aurora, CO; 5Department of Medicine, Division of Cardiology, National Jewish Health, Denver, CO; and 6Denver Veterans Affairs Medical Center, Denver, CO.
Abstract
PURPOSE: People with uncomplicated type 2 diabetes (T2D) have impaired peak exercise performance compared with that of their nondiabetic counterparts. This impairment may represent the earliest indication of cardiovascular (CV) abnormalities in T2D. Women with T2D are known to have worse CV outcomes than those in men with T2D. We hypothesized that women with diabetes have a greater exercise impairment than that in men with diabetes compared with that in their nondiabetic counterparts. METHODS: We studied 15 women (premenopausal) and 14 men with T2D as well as their nondiabetic counterparts (22 women and 13 men). Exercise testing was performed. Additional outcomes included measurements of insulin sensitivity, endothelial function, blood flow, and resting cardiac function. RESULTS: Men and women with T2D but not controls had impaired insulin sensitivity. Women with T2D had a lower peak oxygen consumption (V˙O2peak) compared with that of nondiabetic women (24%, P < 0.05) than men with diabetes compared with that in nondiabetic men (16%, P < 0.05) (P value between groups < 0.05). The time constants (phase 2) of the V˙O2 kinetic response tended to be slower in men and women with T2D than those in nondiabetic controls (P = 0.08). There were no differences in resting ventricular function by Doppler echocardiography techniques between groups. Women with T2D had significantly lower flow-mediated dilation and blood flow responses to hyperemia than those in nondiabetic women (both P < 0.05), whereas men with T2D had lower flow-mediated dilation but not lower blood flow than those in nondiabetic men. CONCLUSIONS: Although both men and women with uncomplicated T2D had a lower V˙O2peak, the abnormality in women with T2D compared with that in nondiabetic women was greater than that seen in men. Because V˙O2peak has a strong inverse correlation with mortality, sex disparities observed in exercise capacity among people with T2D suggest a possible rationale for the increased CV morbidity and mortality observed in women compared with those observed in men with uncomplicated T2D.
PURPOSE:People with uncomplicated type 2 diabetes (T2D) have impaired peak exercise performance compared with that of their nondiabetic counterparts. This impairment may represent the earliest indication of cardiovascular (CV) abnormalities in T2D. Women with T2D are known to have worse CV outcomes than those in men with T2D. We hypothesized that women with diabetes have a greater exercise impairment than that in men with diabetes compared with that in their nondiabetic counterparts. METHODS: We studied 15 women (premenopausal) and 14 men with T2D as well as their nondiabetic counterparts (22 women and 13 men). Exercise testing was performed. Additional outcomes included measurements of insulin sensitivity, endothelial function, blood flow, and resting cardiac function. RESULTS:Men and women with T2D but not controls had impaired insulin sensitivity. Women with T2D had a lower peak oxygen consumption (V˙O2peak) compared with that of nondiabetic women (24%, P < 0.05) than men with diabetes compared with that in nondiabetic men (16%, P < 0.05) (P value between groups < 0.05). The time constants (phase 2) of the V˙O2 kinetic response tended to be slower in men and women with T2D than those in nondiabetic controls (P = 0.08). There were no differences in resting ventricular function by Doppler echocardiography techniques between groups. Women with T2D had significantly lower flow-mediated dilation and blood flow responses to hyperemia than those in nondiabetic women (both P < 0.05), whereas men with T2D had lower flow-mediated dilation but not lower blood flow than those in nondiabetic men. CONCLUSIONS: Although both men and women with uncomplicated T2D had a lower V˙O2peak, the abnormality in women with T2D compared with that in nondiabetic women was greater than that seen in men. Because V˙O2peak has a strong inverse correlation with mortality, sex disparities observed in exercise capacity among people with T2D suggest a possible rationale for the increased CV morbidity and mortality observed in women compared with those observed in men with uncomplicated T2D.
Authors: Miguel A Quiñones; Catherine M Otto; Marcus Stoddard; Alan Waggoner; William A Zoghbi Journal: J Am Soc Echocardiogr Date: 2002-02 Impact factor: 5.251
Authors: W R Hiatt; S Y Huang; J G Regensteiner; A J Micco; G Ishimoto; M Manco-Johnson; J Drose; J T Reeves Journal: J Appl Physiol (1985) Date: 1989-05
Authors: W L Henry; A DeMaria; R Gramiak; D L King; J A Kisslo; R L Popp; D J Sahn; N B Schiller; A Tajik; L E Teichholz; A E Weyman Journal: Circulation Date: 1980-08 Impact factor: 29.690
Authors: Rebecca L Scalzo; Deirdre Rafferty; Irene Schauer; Amy G Huebschmann; Melanie Cree-Green; Jane E B Reusch; Judith G Regensteiner Journal: J Diabetes Complications Date: 2019-05-10 Impact factor: 2.852
Authors: Rebecca L Scalzo; Kerrie L Moreau; Cemal Ozemek; Leah Herlache; Shawna McMillin; Sarah Gilligan; Amy G Huebschmann; Tim A Bauer; Jennifer Dorosz; Jane E B Reusch; Judith G Regensteiner Journal: J Diabetes Complications Date: 2016-10-07 Impact factor: 2.852
Authors: Amy G Huebschmann; Rachel R Huxley; Wendy M Kohrt; Philip Zeitler; Judith G Regensteiner; Jane E B Reusch Journal: Diabetologia Date: 2019-08-27 Impact factor: 10.122
Authors: Melissa L Erickson; Jacob M Allen; Daniel P Beavers; Linda M Collins; Karina W Davidson; Kirk I Erickson; Karyn A Esser; Matthijs K C Hesselink; Kerrie L Moreau; Eric B Laber; Charlotte A Peterson; Courtney M Peterson; Jane E Reusch; John P Thyfault; Shawn D Youngstedt; Juleen R Zierath; Bret H Goodpaster; Nathan K LeBrasseur; Thomas W Buford; Lauren M Sparks Journal: Geroscience Date: 2022-10-15 Impact factor: 7.581
Authors: Yu-Sok Kim; Thomas Seifert; Patrice Brassard; Peter Rasmussen; Allan Vaag; Henning B Nielsen; Niels H Secher; Johannes J van Lieshout Journal: Physiol Rep Date: 2015-06
Authors: A G Huebschmann; W M Kohrt; L Herlache; P Wolfe; S Daugherty; J Eb Reusch; T A Bauer; J G Regensteiner Journal: BMJ Open Diabetes Res Care Date: 2015-09-30
Authors: Genevieve A Wilson; Gerard T Wilkins; Jim D Cotter; Regis R Lamberts; Sudish Lal; James C Baldi Journal: Cardiovasc Diabetol Date: 2017-12-19 Impact factor: 9.951
Authors: Rebecca L Scalzo; Irene E Schauer; Deirdre Rafferty; Leslie A Knaub; Nina Kvaratskhelia; Taro Kaelix Johnson; Gregory B Pott; Layla A Abushamat; Mary O Whipple; Amy G Huebschmann; Melanie Cree-Green; Jane E B Reusch; Judith G Regensteiner Journal: J Physiol Date: 2021-03-05 Impact factor: 5.182